BTC$59,264.00-1.26%
ETH$1,583.48+0.46%
USDT$0.9984-0.02%
BNB$548.76-0.81%
USDC$0.9996-0.01%
XRP$1.04-1.04%
SOL$73.53+0.46%
TRX$0.3176-1.72%
FIGR_HELOC$1.05+2.60%
HYPE$65.53+3.26%
DOGE$0.0724-0.57%
RAIN$0.0158+1.40%
USDS$0.9994-0.02%
LEO$9.52+1.31%
ZEC$392.66+2.26%
XLM$0.178+3.24%
BTC$59,264.00-1.26%
ETH$1,583.48+0.46%
USDT$0.9984-0.02%
BNB$548.76-0.81%
USDC$0.9996-0.01%
XRP$1.04-1.04%
SOL$73.53+0.46%
TRX$0.3176-1.72%
FIGR_HELOC$1.05+2.60%
HYPE$65.53+3.26%
DOGE$0.0724-0.57%
RAIN$0.0158+1.40%
USDS$0.9994-0.02%
LEO$9.52+1.31%
ZEC$392.66+2.26%
XLM$0.178+3.24%
TeraWulf’s pivot into AI and HPC hosting, backed by Google’s investment, positions it at the intersection of Bitcoin scarcity and the AI compute boom.
HCW Biologics stock surged 85.5% after announcing a breakthrough second-generation immune checkpoint inhibitor that outperformed existing cancer treatments.
Global stock exchanges are pressuring regulators to restrict tokenized stocks, putting Coinbase and Robinhood at risk.
Gold’s dual role as an inflation hedge and economic safety net positions leading miners like Franco-Nevada, Barrick, and Newmont for continued upside
Fed Chair Powell's Jackson Hole speech hinted at potential policy adjustments as economic conditions evolve, with markets rallying on his balanced approach.
Workday beats Q2 earnings but stock slides on disappointing subscription revenue outlook and growth concerns.
Delta and United Airlines face class-action lawsuits for allegedly charging passengers extra fees for "window seats" that lack actual windows.
Evoke Pharma shares soared 25% in premarket trading after announcing FDA Orange Book listing of a new GIMOTI patent extending protection to 2038.
The company’s Q2 report will highlight not just financial strength but the delicate balance between U.S. policy, China sales, and global AI dominance.
MIT’s “GenAI Divide” report has been somewhat misinterpreted in ways that spooked investors and sent tech markets tumbling.
Intel’s fate is increasingly tied to geopolitics as it stands beside - and against - TSMC in shaping the U.S. tech stack.
Target's stock dropped over 10% premarket after reporting Q2 earnings and announcing a new CEO transition.
Technological, economic and demographic fundamentals are turning in Richtech Robotics’ favor.